Androst-16-en-3-ol CAS: 7148-51-8

CAS NO: 7148-51-8
Androst-16-en-3-ol
Chemical Name: 16,(5-ALPHA)-ANDROSTEN-3-BETA-OL
Molecular Formula: C19H30O
Formula Weight: 274.44
CAS No.: 7148-51-8
Description Review
Description

Androst-16-en-3-ol, also known as androstenol or 5α-androst-16-en-3-ol, is a natural steroid hormone that is primarily produced in the adrenal glands and reproductive organs. Its chemical name is (5S,8R,9S,10S,13S,14S)-3-Hydroxy-10,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15-dodecahydrocyclopenta[a]phenanthren-17-one, its molecular formula is C19H30O2, and its molecular weight is 290.45 g/mol. The CAS number for Androst-16-en-3-ol is 7148-51-8.

Top Ten Keywords from Google and Synonyms:

  1. Hormone
  2. Pheromone
  3. Androstenol
  4. Attractiveness
  5. Sexual attraction
  6. Olfactory receptor
  7. Scent
  8. Mood
  9. Social behavior
  10. Reproduction

Health Benefits of Androst-16-en-3-ol: While Androst-16-en-3-ol is primarily known for its potential effects on social and sexual behavior, it may also have other health benefits. Some studies have suggested that it could have anti-inflammatory and antioxidant properties, which could help to promote overall health and well-being.

Potential Effects of Androst-16-en-3-ol: Androst-16-en-3-ol has been shown to produce a range of effects on human behavior and mood. It is believed to play a role in sexual attraction and social bonding, and may be detected by the olfactory receptors. Some studies have also suggested that it may have a positive impact on mood and could help to reduce anxiety and stress.

Product Mechanism: The mechanism of action for Androst-16-en-3-ol is not yet fully understood, but it is believed to work by interacting with certain receptors in the brain and olfactory system. It may also have some hormonal effects, although these are not as well-established.

Safety: Androst-16-en-3-ol is generally considered safe when used appropriately, although there is still much we do not know about its long-term effects on health. Some people may experience mild side effects such as headaches or nausea, although these typically resolve quickly.

Side Effects: Androst-16-en-3-ol is not associated with significant side effects at typical doses. However, excessive consumption could potentially lead to more serious effects such as hormonal imbalances or liver toxicity.

Dosing Information: There is no established dosing regimen for Androst-16-en-3-ol, as it is not intended for medical use. Instead, it is typically used in small quantities as part of fragrances and other cosmetic products.

Conclusion: Overall, Androst-16-en-3-ol is an interesting natural compound with potential effects on human behavior and mood. While more research is needed to fully understand its mechanisms of action and long-term effects, early findings suggest that it may be a promising tool in the exploration of human pheromones and their impact on social and sexual behavior. If you are considering using Androst-16-en-3-ol-containing products, it is important to proceed with caution and to seek guidance from a qualified healthcare provider or fragrance expert if necessary.

Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code